Impact of Molybdenum Compounds as Anticancer Agents-Reference-Cited by-同舟云学术

Impact of Molybdenum Compounds as Anticancer Agents

Published:2019-09-10 Issue: Volume:2019 Page:1-9
ISSN:1565-3633
Container-title:Bioinorganic Chemistry and Applications
language:en
Short-container-title:Bioinorganic Chemistry and Applications

Author:

Odularu Ayodele T.¹^ORCID,Ajibade Peter A.²^ORCID,Mbese Johannes Z.¹^ORCID

Affiliation:

1. Department of Chemistry, University of Fort Hare, Private Bag X1314, Alice 5700, South Africa

2. School of Chemistry and Physics, University of KwaZulu-Natal, Pietermaritzburg Campus, Scottsville 3209, South Africa

Abstract

The aim of this mini review was to report the molybdenum compound intervention to control cancer disease. The intervention explains its roles and progress from inorganic molybdenum compounds via organomolybdenum complexes to its nanoparticles to control oesophageal cancer and breast cancer as case studies. Main contributions of molybdenum compounds as anticancer agents could be observed in their nanofibrous support with suitable physicochemical properties, combination therapy, and biosensors (biomarkers). Recent areas in anticancer drug design, which entail the uses of selected targets, were also surveyed and proposed.

Funder

Govan Mbeki Research and Development Centre

Publisher

Hindawi Limited

Subject

Inorganic Chemistry,Organic Chemistry,Biochemistry

Link

http://downloads.hindawi.com/journals/bca/2019/6416198.pdf

Reference105 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018

3. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods